Male pattern baldness and prostate cancer risk in a population-based case-control study

被引:29
作者
Wright, Jonathan L. [1 ,2 ]
Page, Stephanie T. [3 ]
Lin, Daniel W. [1 ,2 ]
Stanford, Janet L. [1 ,4 ]
机构
[1] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA
[2] Univ Washington, Sch Med, Dept Urol, Seattle, WA 98195 USA
[3] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA
[4] Univ Washington, Dept Epidemiol, Sch Publ Hlth, Seattle, WA 98195 USA
关键词
Prostate cancer; Male pattern baldness; Relative risk; Population based; ANDROGENETIC ALOPECIA; FINASTERIDE; MEN; HAIR; RECEPTOR; 5-ALPHA-REDUCTASE; TESTOSTERONE; ASSOCIATIONS; POLYMORPHISM; HYPERPLASIA;
D O I
10.1016/j.canep.2010.02.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Male pattern baldness (MPB) and prostate cancer (PCa) share commonality as prevalent, heritable and androgen-related conditions. Studies exploring the relationship between the two conditions have been inconclusive. Using a population-based, case-control study of PCa, we explore the relationship between early-onset MPB and PCa risk. Methods: Cases were men aged 35-74 diagnosed with PCa between 2002 and 2005 in King County, Washington. Controls were frequency matched by age and identified by random digit dialing. Hair pattern at age 30 and at 1 year prior to diagnosis (cases) or reference date (controls) was determined using showcards. PCa risk associated with balding was assessed with logistic regression. Results: Data from 999 cases of PCa and 942 controls were analyzed. Hair loss at age 30 was more common in controls (25.2%) than cases (19.8%, p = 0.005), and those with hair loss at age 30 had a 29% relative risk reduction for PCa (OR 0.71, 95% CI 0.56-0.91). No risk reduction was seen for men only reporting hair loss at referent age (OR 0.90,95% CI 0.73-1.12). In men aged >60 at referent date, the risk reduction was greater for men with hair loss at age 30 from both the top of head and forehead (OR 0.55, 95% CI 0.33-0.93). Conclusion: Early-onset MPB was associated with a reduced relative risk of PCa in this population-based study. Further research into a possible mechanistic link between these prevalent and androgen-related conditions is warranted. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:131 / 135
页数:5
相关论文
共 34 条
[1]   Statin use and risk of prostate cancer: Results from a population-based epidemiologic study [J].
Agalliu, Ilir ;
Salinas, Claudia A. ;
Hansten, Philip D. ;
Ostrander, Elaine A. ;
Stanford, Janet L. .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2008, 168 (03) :250-260
[2]  
[Anonymous], 2006, SEER cancer statistics review, 1975-2003
[3]   Comparative studies on level of androgens in hair and plasma with premature mate-pattern baldness [J].
Bang, HJ ;
Yang, YJ ;
Lho, DS ;
Lee, WY ;
Sim, WY ;
Chung, BC .
JOURNAL OF DERMATOLOGICAL SCIENCE, 2004, 34 (01) :11-16
[4]  
BARRETTCONNOR E, 1990, CANCER RES, V50, P169
[5]   Value of hormonal levels in patients with male androgenetic alopecia treated with finasteride:: better response in patients under 26 years old [J].
Camacho, F. M. ;
Garcia-Hernandez, M. J. ;
Fernandez-Crehuet, J. L. .
BRITISH JOURNAL OF DERMATOLOGY, 2008, 158 (05) :1121-1124
[6]   Patients with a large prostate show a higher prevalence of androgenetic alopecia [J].
Chen, WC ;
Yang, CC ;
Chen, GY ;
Wu, MC ;
Sheu, HM ;
Tzai, TS .
ARCHIVES OF DERMATOLOGICAL RESEARCH, 2004, 296 (06) :245-249
[7]   Biochemical roles of testosterone and epitestosterone to 5α-reductase as indicators of male-pattern baldness [J].
Choi, MH ;
Yoo, YS ;
Chung, BC .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2001, 116 (01) :57-61
[8]   Hormonal, cellular, and molecular regulation of normal and neoplastic prostatic development [J].
Cunha, GR ;
Ricke, W ;
Thomson, A ;
Marker, PC ;
Risbridger, G ;
Hayward, SW ;
Wang, YZ ;
Donjacour, AA ;
Kurita, T .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2004, 92 (04) :221-236
[9]  
Delongchamps Nicolas B, 2006, Cancer Control, V13, P158
[10]  
Demark-Wahnefried W, 2000, CANCER EPIDEM BIOMAR, V9, P325